» Articles » PMID: 26683953

Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study

Overview
Specialty General Medicine
Date 2015 Dec 20
PMID 26683953
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of hepatitis B virus (HBV) infection on bone mineral density in patients without advanced liver disease remains unclear. Hence, we assessed the association between HBV infection and the risk of osteoporosis. From 2000 to 2011, patients older than 20 years with HBV infection were identified from the Longitudinal Health Insurance Database 2000. Of the 180,730 sampled patients, 36,146 and 144,584 patients were categorized into HBV infection and comparison cohorts, respectively. Compared with the comparison cohort, the HBV infection patients had a higher risk of osteoporosis (adjusted hazard ratio [aHR]: 1.14, 95% confidence interval [CI]: 1.03-1.25) after adjusting for age, sex, frequency of medical visits, and comorbidities of diabetes, hypertension, hyperlipidemia, heart failure, cirrhosis, chronic kidney disease, thyroid diseases, medication of steroid, PPI, warfarin, aspirin, and estrogen replacement therapy. The patients with HBV infection exhibited a 1.13-fold (95% CI = 1.03-1.25) higher risk of developing osteoporosis, but the risk of osteoporotic fracture was comparable between patients with HBV infection and the comparison cohort (aHR = 1.20, 95% CI = 0.77-1.86). The incidence of osteoporosis increased with the increment of age (age  ≤ 49: aHR = 1; age 50-64: aHR = 5.67, 95% CI = 5.09-6.32; age  ≧ 65: aHR = 13.3, 95% CI = 11.8-14.9) and coexisting cirrhosis (aHR = 1.62, 95% CI = 1.24-2.12). However, the osteoporosis risk contributed by HBV infection decreased with age and the age-specific risk analyses showed that patients with HBV infection exhibited the highest risk of osteoporosis than patients without HBV infection for the patients aged ≤49 (aHR = 1.42, 95% CI = 1.19-1.70). Furthermore, the osteoporosis risk contributed by HBV infection has decreased with the presence of comorbidity (aHR = 1.27, 95% CI = 1.09-1.48 vs aHR = 1.04, 95% CI = 0.91-1.15). HBV increases the risk of osteoporosis, but HBV infection may be less influential than other risk factors. Moreover, HBV has no detrimental effect on osteoporotic fracture in this study.

Citing Articles

Emerging role of liver-bone axis in osteoporosis.

Gao H, Peng X, Li N, Gou L, Xu T, Wang Y J Orthop Translat. 2024; 48:217-231.

PMID: 39290849 PMC: 11407911. DOI: 10.1016/j.jot.2024.07.008.


Do patients with nephrotic syndrome have an increased risk of osteoporosis? A nationwide population-based retrospective cohort study in Taiwan.

Liao C, Chung C, Wei K, Tseng M, Lin F, Tsao C BMJ Open. 2024; 14(5):e080858.

PMID: 38719315 PMC: 11086532. DOI: 10.1136/bmjopen-2023-080858.


Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece.

Sinakos E, Kachru N, Tsoulas C, Jeyakumar S, Smith N, Yehoshua A J Comp Eff Res. 2024; 13(4):e230090.

PMID: 38317634 PMC: 11044955. DOI: 10.57264/cer-2023-0090.


Association of chronic liver disease with bone diseases and muscle weakness.

Saeki C, Saito M, Tsubota A J Bone Miner Metab. 2024; 42(4):399-412.

PMID: 38302761 DOI: 10.1007/s00774-023-01488-x.


Human Papillomavirus Infections and Increased Risk of Incident Osteoporosis: A Nationwide Population-Based Cohort Study.

Ma K, Chin N, Tu T, Wu Y, Yip H, Cheng-Chung Wei J Viruses. 2023; 15(4).

PMID: 37113002 PMC: 10143035. DOI: 10.3390/v15041021.


References
1.
Byrne D, Newcomb C, Carbonari D, Nezamzadeh M, Leidl K, Herlim M . Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. J Hepatol. 2014; 61(2):210-8. PMC: 4262153. DOI: 10.1016/j.jhep.2014.04.001. View

2.
Chen C, Yang H . Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol. 2011; 26(4):628-38. DOI: 10.1111/j.1440-1746.2011.06695.x. View

3.
Orimo H, Nakamura T, Hosoi T, Iki M, Uenishi K, Endo N . Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary. Arch Osteoporos. 2012; 7:3-20. PMC: 3517709. DOI: 10.1007/s11657-012-0109-9. View

4.
Jinjuvadia R, Liangpunsakul S . Association between metabolic syndrome and its individual components with viral hepatitis B. Am J Med Sci. 2013; 347(1):23-7. PMC: 3723745. DOI: 10.1097/MAJ.0b013e31828b25a5. View

5.
Chen C, Yang J, Lin S, Sun C, Bai C, You S . Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. J Hepatol. 2015; 63(2):354-63. DOI: 10.1016/j.jhep.2015.03.013. View